Elon Musk's Brain Implant Venture, Neuralink, has secured approval from the US Food and Drug Administration to conduct human trials...
FDA & New Drug
The U.S. Food and Drug Administration recently published a report highlighting the benefits and risks of emerging augmented and virtual...
BioMarin Pharmaceutical has introduced its gene therapy, Roctavian, in Europe, marking a significant breakthrough for severe haemophilia A patients. The...
FDA has given Orphan Drug Designation to Faron Pharmaceuticals' bexmarilimab, a treatment designed for acute myeloid leukaemia. This breakthrough in drug designation is set to bring advantages...Read more
AbbVie has applied to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval for a new indication of risankizumab (Skyrizi) for treating...Read more
The European Commission has approved Merck’s Keytruda, in combination with other drugs, for the treatment of gastric or gastroesophageal junction adenocarcinoma. Keytruda, an anti-PD-1 therapy, is the...Read more
The U.S. Food and Drug Administration (FDA) has enhanced the approval parameters for Bristol Myers Squibb's Reblozyl, paving the way for its broader application in treating myelodysplastic...Read more
The Food and Drug Administration (FDA) has given the green light to Novartis for its drug Tyruko, a biosimilar of Biogen’s blockbuster Tysabri, paving the way for...Read more
The FDA has granted approval to Roctavian, the first-ever gene therapy for severe Hemophilia A. Developed by BioMarin, this revolutionary treatment seeks to replace a faulty gene...Read more
FDA has greenlit the first gene therapy, Elevidys, designed for pediatric patients with Duchenne muscular dystrophy (DMD) - a condition caused by a defective gene that leads...Read more
Startup's success, the US Food and Drug Administration (FDA) has granted approval to CellTrans's Lantidra, marking the first-ever cell therapy to treat patients with type 1 diabetes.Read more